Renal Safety Issues of Intravenous Iodinated Contrast Media Are Questionable

Bernardo Vidal Pimentel; Pedro Caiado Ferreira; Mariana Barosa

doi:10.20344/amp.22484

Renal Safety Issues of Intravenous Iodinated Contrast Media Are Questionable

Authors

Bernardo Vidal Pimentel Department of Internal Medicine. Hospital da Luz Lisboa. Lisbon. Portugal.
Pedro Caiado Ferreira Department of Internal Medicine 3.2. Centro Hospitalar Universitário Lisboa Central. Lisboa.
Mariana Barosa NOVA Medical School. Universidade NOVA de Lisboa. Lisbon.

DOI:

https://doi.org/10.20344/amp.22484

Keywords:

Acute Kidney Injury/chemically induced, Contrast Media/adverse effects

Abstract

N/A

Downloads

Download data is not yet available.

References

Freitas F. An algorithm for waiting times between imaging studies with contrast media and prevention of interference in clinical laboratory tests. Acta Med Port. 2024;37:407-8.

Thomsen HS. ESUR Guidelines on Contrast Agents. European Society of Urogenital Radiology. [cited 2024 Nov 30]. Available from: www.esur.org/esurguidelines-on-contrast-agents/.

Davenport MS, Perazellac MA, Nallamothu BK. Contrast-induced acute kidney injury and cardiovascular imaging: danger or distraction? Circ. 2023;147:847-9.

Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380:2146-55.

Aycock RD, Westafer LM, Boxen JL, Majlesi N, Schoenfeld EM, Bannuru RR. Acute kidney injury after computed tomography: a meta-analysis. Ann Emerg Med. 2018;71:44-53.

Goulden R, Rowe BH, Abrahamowicz M, Strumpf E, Tamblyn R. Association of intravenous radiocontrast with kidney function: a regression discontinuity analysis. JAMA Intern Med. 2021;181:767-74.

Ehmann MR, Mitchell J, Levin S, Smith A, Menez S, Hinson JS, et al. Renal outcomes following intravenous contrast administration in patients with acute kidney injury: a multi-site retrospective propensity-adjusted analysis. Intensive Care Med. 2023;49:205-15.

Topf J. Contrast-Associated Acute Kidney Injury Is a Meaningless Endpoint. Medscape. 2022. [cited 2024 Nov 30]. Available from: https://www.medscape.com/viewarticle/971433.

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294:660-8.

Macdonald DB, Hurrell CD, Costa AF, McInnes MD, O’Malley M, Barrett B, et al. Canadian association of radiologists guidance on contrast-associated acute kidney injury. Can J Kidney Health Dis. 2022;9:20543581221097455.

Downloads

22484_AOP.pdf

Published

2025-03-07

How to Cite

Vidal Pimentel B, Caiado Ferreira P, Barosa M. Renal Safety Issues of Intravenous Iodinated Contrast Media Are Questionable. Acta Med Port [Internet]. 2025 Mar. 7 [cited 2025 Mar. 9];. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/22484

Download Citation

Issue

In Press

Section

Perspective

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.